# Female sex is a risk factor for exacerbated lipid peroxidation and disease in murine retinitis pigmentosa

**Authors:** Katri Vainionpää, Anna Kalatanova, Umair Seemab, Ahmed B. Montaser, Henri Leinonen

PMC · DOI: 10.1016/j.redox.2025.103987 · Redox Biology · 2025-12-23

## TL;DR

Female mice show faster retinal disease progression due to increased lipid damage, starting after sexual maturity.

## Contribution

Female sex is identified as a risk factor for accelerated retinal degeneration linked to lipid peroxidation in mouse models.

## Key findings

- Disease progression in female RP mice coincides with sexual maturity and increased retinal lipid peroxidation.
- Female mice have higher levels of polyunsaturated fatty acid-containing lipids in retinas compared to males.
- Sex-related differences in retinal energy metabolism pathways were observed in human transcriptomic data.

## Abstract

Oxidative stress is an important aspect in retinal degenerations that could be targeted in various forms of currently untreatable diseases. It is generally believed that males are more predisposed to oxidative stress than females due to their higher metabolic activity and/or lower antioxidant capacity. However, studies using mouse disease models have demonstrated that photoreceptor degeneration progresses faster in females. Sex hormones likely play a role, but the cellular mechanism behind the sex difference is unclear. In the current study, we confirmed that the accelerated disease phenotype in female rd10 and P23H retinitis pigmentosa mice coincides with sexual maturity, and further, we found that it co-occurs with increased retinal lipid peroxidation. Instead, protein oxidation and inflammatory marker levels were similar between the sexes. Retinal lipid profiling revealed higher levels of polyunsaturated fatty acid (PUFA)-containing lipids in healthy 2-month-old female mice compared to males, whereas before puberty the sex difference in retinal PUFAs was absent. However, the association between elevated long-chain PUFAs in female C57BL/6J mouse retinas and the increased lipid peroxidation in female RP mice on the same background remains correlative rather than causal. Analysis of open bulk retina transcriptomic data from middle-aged humans found supplemental evidence of sex-related differences in retinal energy metabolism pathways. In addition to mechanistic studies aimed at uncovering the causes of differential lipid peroxidation between sexes, further research is needed to investigate sex differences in retinal metabolism and lipid composition across animal species. Our findings highlight the importance of considering sex differences when conducting preclinical experiments using RP models.

•Female sex is a risk factor for disease rate in retinitis pigmentosa mouse models.•The sex-difference in disease progression starts after mice reach sexual maturity.•Retinal lipid peroxidation is exacerbated in young adult female retinitis pigmentosa mice.

Female sex is a risk factor for disease rate in retinitis pigmentosa mouse models.

The sex-difference in disease progression starts after mice reach sexual maturity.

Retinal lipid peroxidation is exacerbated in young adult female retinitis pigmentosa mice.

## Linked entities

- **Diseases:** retinitis pigmentosa (MONDO:0008377)
- **Species:** Mus musculus (taxon 10090), Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** Blnk (B cell linker) [NCBI Gene 17060] {aka BASH, Bca, Ly-57, Ly57, Lyw-57, SLP-65}, Irf8 (interferon regulatory factor 8) [NCBI Gene 15900] {aka ICSBP, IRF-8, Icsbp1, Myls}, Abca4 (ATP-binding cassette, sub-family A member 4) [NCBI Gene 11304] {aka Abc10, Abcr, D430003I15Rik, RmP}, PDE10A (phosphodiesterase 10A) [NCBI Gene 10846] {aka ADSD2, HSPDE10A, IOLOD, PDE10A19}, FOSB (FosB proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 2354] {aka AP-1, G0S3, GOS3, GOSB}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, S100b (S100 protein, beta polypeptide, neural) [NCBI Gene 20203] {aka Bpb}, Gfap (glial fibrillary acidic protein) [NCBI Gene 14580], Esr1 (estrogen receptor 1 (alpha)) [NCBI Gene 13982] {aka ER, ER-alpha, ERa, ERalpha, ESR, Estr}, Gpx4 (glutathione peroxidase 4) [NCBI Gene 625249] {aka GPx-4, GSHPx-4, PHGPx, mtPHGPx, snGPx}, Cat (catalase) [NCBI Gene 12359] {aka 2210418N07, Cas-1, Cas1, Cs-1}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Pde6b (phosphodiesterase 6B, cGMP, rod receptor, beta polypeptide) [NCBI Gene 18587] {aka Pdeb, r, rd, rd-1, rd1, rd10}, Ppargc1a (peroxisome proliferative activated receptor, gamma, coactivator 1 alpha) [NCBI Gene 19017] {aka A830037N07Rik, Gm11133, PGC-1, PPARGC-1-alpha, Pgc-1alpha, Pgc1}, PCK1 (phosphoenolpyruvate carboxykinase 1) [NCBI Gene 5105] {aka PCKDC, PEPCK-C, PEPCK1, PEPCKC}, Ar (androgen receptor) [NCBI Gene 11835] {aka Tfm}, Rho (rhodopsin) [NCBI Gene 212541] {aka Noerg1, Opn2, Ops, RP4}, Fdxr (ferredoxin reductase) [NCBI Gene 14149] {aka AR}, Esr2 (estrogen receptor 2 (beta)) [NCBI Gene 13983] {aka ER[b], ERbeta, Estrb}, Vim (vimentin) [NCBI Gene 22352], DPP4 (dipeptidyl peptidase 4) [NCBI Gene 1803] {aka ADABP, ADCP2, CD26, DPPIV, TP103}, Itgam (integrin alpha M) [NCBI Gene 16409] {aka CD11b/CD18, CR3, CR3A, Cd11b, F730045J24Rik, Ly-40}, Sod2 (superoxide dismutase 2, mitochondrial) [NCBI Gene 20656] {aka MnSOD, Sod-2}, Sdha (succinate dehydrogenase complex, subunit A, flavoprotein (Fp)) [NCBI Gene 66945] {aka 1500032O14Rik, 2310034D06Rik, 4921513A11, FP, SDH2, SDHF}, Acaa2 (acetyl-CoA acyltransferase 2) [NCBI Gene 52538] {aka 0610011L04Rik, D18Ertd240e}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Sod1 (superoxide dismutase 1, soluble) [NCBI Gene 20655] {aka B430204E11Rik, Cu/Zn-SOD, CuZnSOD, Ipo-1, Ipo1, SODC}, ACAA2 (acetyl-CoA acyltransferase 2) [NCBI Gene 10449] {aka DSAEC, T1}
- **Diseases:** AMD (MESH:D008268), retinal detachment (MESH:D012163), cataract (MESH:D002386), degenerative photoreceptor diseases (MESH:D019636), IRDs (MESH:D012162), loss of night vision (MESH:D014786), IRD (MESH:D052919), STGD (MESH:D000080362), genetic (MESH:D030342), eye diseases (MESH:D005128), rod degeneration (MESH:D000071700), neuronal ceroid lipofuscinosis (MESH:D009472), photoreceptor degeneration (MESH:D009410), retinal inflammation (MESH:D012173), diabetic retinopathy (MESH:D003930), cardiovascular disease (MESH:D002318), death (MESH:D003643), glaucoma (MESH:D005901), corneal opacity (MESH:D003318), gliosis (MESH:D005911), Collateral cone degeneration (MESH:C566719), amyotrophic lateral sclerosis (MESH:D000690), Inflammatory (MESH:D007249), dislocation (MESH:D004204), blindness (MESH:D001766), fields (MESH:D007922), RP (MESH:D012174)
- **Chemicals:** PI (MESH:D010716), lysobisphosphatidic acid (MESH:C012786), PE (MESH:C483858), cholesteryl ester (MESH:D002788), phosphatidylethanolamines (MESH:D010714), ammonium formate (MESH:C030544), glucose (MESH:D005947), FeCl2 (MESH:C029451), methanol (MESH:D000432), 4',6-diamidino-2-phenylindole (MESH:C007293), sodium borohydride (MESH:C025364), trifluoroacetic acid (MESH:D014269), lysophosphatidylcholine (MESH:D008244), medetomidine (MESH:D020926), SDS (MESH:D012967), nitrogen (MESH:D009584), AA (MESH:D016718), fatty acid (MESH:D005227), Alexa Fluor 488 (MESH:C000711379), coenzyme Q9 (MESH:C030571), Lipid (MESH:D008055), superoxide radicals (MESH:D013481), citric acid (MESH:D019343), Co (MESH:D014451), carnitine (MESH:D002331), cyclic nucleotides (MESH:D009712), ceramide (MESH:D002518), Ascorbic acid (MESH:D001205), Acetonitrile (MESH:C032159), estradiol (MESH:D004958), TBS (MESH:D013725), guanidine hydrochloride (MESH:D019791), PG (MESH:D010715), sphingomyelin (MESH:D013109), Isopropanol (MESH:D019840), DNP (MESH:D019297), 2-MO (-), DPA (MESH:C026219), PVDF (MESH:C024865), acylcarnitine (MESH:C116917), ICE (MESH:D007053), sucrose (MESH:D013395), 2,2-diphenyl-1-picrylhydrazyl (MESH:C004931), PS (MESH:D010718), PC (MESH:D010713), ROS (MESH:D017382), monoacylglycerol (MESH:D050178), CoA (MESH:D003065), retinal (MESH:D012172), oxygen (MESH:D010100), hydrazine (MESH:C029424), glycerol (MESH:D005990), PUFA (MESH:D005231), potassium phosphate (MESH:C013216), streptomycin (MESH:D013307), testosterone (MESH:D013739), EDTA (MESH:D004492), reserpine (MESH:D012110), carbon (MESH:D002244), DG (MESH:D004075)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Rattus norvegicus (brown rat, species) [taxon 10116], Rodentia (rodent, order) [taxon 9989], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** C in 50, P23H, R560C, C at 10, P23H, G at 4
- **Cell lines:** C57BL/6J — Mus musculus (Mouse), Transformed cell line (CVCL_C0MW), /6J — Homo sapiens (Human), Cutaneous melanoma, Cancer cell line (CVCL_W797), RPE — Homo sapiens (Human), Spontaneously immortalized cell line (CVCL_IQ82)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12870477/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12870477/full.md

## References

86 references — full list in the complete paper: https://tomesphere.com/paper/PMC12870477/full.md

---
Source: https://tomesphere.com/paper/PMC12870477